UBS Maintains a 'Buy' on Johnson & Johnson (JNJ); Zytiga (abiraterone) Approved
Go back to UBS Maintains a 'Buy' on Johnson & Johnson (JNJ); Zytiga (abiraterone) Approved| Johnson & Johnson (NYSE: JNJ) | Delayed: 270.24 +2.87 (1.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $267.37 | 52 Week High | $126.07 | |||
| Open | $267.83 | 52 Week Low | $94.28 | |||
| Day High | $272.66 | P/E | 56.18 | |||
| Day Low | $267.00 | EPS | $4.81 | |||
| Volume | 6,186,620 | |||||
| Medivation, Inc. (NASDAQ: MDVN) | Delayed: 81.44 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $81.44 | 52 Week High | $81.48 | |||
| Open | $3852.47 | 52 Week Low | $26.41 | |||
| Day High | $81.44 | P/E | N/A | |||
| Day Low | $81.44 | EPS | $-1.03 | |||
| Volume | 13,593 | |||||
